• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respirol Case Rep . Post-mortem biopsy of a patient with late exacerbation of COVID-19 pneumonia

tetano

Editor, Senior Moderator
Respirol Case Rep


. 2021 Feb 22;9(4):e00724.
doi: 10.1002/rcr2.724. eCollection 2021 Apr.
Post-mortem biopsy of a patient with late exacerbation of COVID-19 pneumonia


Kuniko Takahashi[SUP] 1 [/SUP], Koichiro Kajiura[SUP] 2 [/SUP], Michitaka Nasu[SUP] 1 [/SUP], Kei Nakamura[SUP] 2 [/SUP], Kazuki Sugata[SUP] 2 [/SUP], Akiko Matsuzaki[SUP] 3 [/SUP]



Affiliations

Abstract

Pathological findings of coronavirus disease (COVID-19) have rarely been reported owing to its contagious nature. Here, we treated an 82-year-old man whose condition was diagnosed as COVID-19 pneumonia, which exacerbated approximately 25 days after the initial onset. The patient died despite receiving intensive care. Post-mortem percutaneous needle biopsy of the lungs and liver tissue was performed, including genomic analysis, immunochemical tests, and pathological studies. Histopathology of the lungs showed both exudative and organizing diffuse alveolar damage. Supposedly, the organizing phase of acute respiratory distress syndrome (ARDS) induced COVID-19. Polymerase chain reaction (PCR) test and immunostaining of biopsy specimens showed negative results for COVID-19. Post-mortem percutaneous needle biopsy was more effective in reducing the risk of contagiousness than autopsy.

Keywords: COVID‐19; PCR; late exacerbation; post‐mortem biopsy.
 
Back
Top Bottom